Kidney dysfunction induced by protein overload nephropathy reduces serum sulfatide levels in mice

Nephrology

Volumn 14, Issue 7, 2009, Pages 658-662

  Li, Gang ^a,b   Hu, Rui ^b,c   Kamijo, Yuji ^d   Nakajima, Takero ^b   Aoyama, Toshifumi ^b   Ehara, Takashi ^d   Shigematsu, Hidekazu ^d   Kannagi, Reiji ^e   Kyogashima, Mamoru ^e,f   Hara, Atsushi ^b  

^a HEBEI GENERAL HOSPITAL   (China)

^b SHINSHU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c HEBEI MEDICAL UNIVERSITY   (China)

^d SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e AICHI CANCER CENTER HOSPITAL   (Japan)

^f NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN; SULFATIDE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; KIDNEY DISEASE; KIDNEY DYSFUNCTION; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ANIMALS; CARDIOVASCULAR DISEASES; DISEASE MODELS, ANIMAL; INTESTINE, SMALL; KIDNEY DISEASES; LIVER; MALE; MICE; PROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SULFOGLYCOSPHINGOLIPIDS;

EID: 70349728223     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2009.01116.x     Document Type: Article

References (21)

1. Ishizuka I. Chemistry and functional distribution of sulfoglycolipids. Prog. Lipid Res. 1997 36 : 245-319.
2. Hara A, Taketomi T. Occurrence of sulfatides as a major glycosphingolipid in WHHL rabbit serum lipoproteins. J. Biochem. (Tokyo) 1987 102 : 83-92.
3. Zalc B, Helwig JJ, Ghandour MS et al. Sulphatide in the kidney: How is this lipid involved in sodium chloride transport. FEBS Lett. 1978 92 : 92-6.
4. Hara A, Taketomi T. Characterization and changes of glycosphingolipids in the aorta of the Watanabe hereditable hyperlipidemic rabbit. J. Biochem. (Tokyo) 1991 109 : 904-908.
5. Kyogashima M, Onaya J, Hara A, Taketomi T. Sulfatide can markedly enhance thrombogenesis in rat deep vein thrombosis model. Glycoconj. J. 1998 15 : 915-922.
6. Kyogashima M. The role of sulfatide in thrombogenesis and haemostasis. Arch. Biochem. Biophys. 2004 426 : 157-162.
7. Hara A, Uemura K-I, Taketomi T. Sulfatide prolongs blood-coagulation time and bleeding time by forming a complex with fibrinogen. Glycoconj. J. 1996 13 : 187-194.
8. Levey A, Beto JA, Coronado BE et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? Am. J. Kidney Dis. 1998 32 : 853-906.
9. Sarnak MJ, Levey AS, Schoolwerth AC et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 2003 108 : 2154-2169.
10. Roberts MA, Hare DL, Ratnaike S, Ierino FL. Cardiovascular biomarkers in CKD: Pathophysiology and implications for clinical management of cardiac disease. Am. J. Kidney Dis. 2006 48 : 341-360.
11. Li G, Hu R, Kamijo Y et al. Establishment of a quantitative, qualitative and high throughput analysis of sulfatides from small amounts of sera by MALDI-TOF MS. Anal. Biochem. 2007 362 : 1 7.
12. Hu R, Li G, Kamijo Y et al. Serum sulfatides as a novel biomarker for cardiovascular disease in patients with end-stage renal failure. Glycoconj. J. 2007 24 : 565 571.
13. Eddy AA. Interstitial nephritis induced by protein-overload proteinuria. Am. J. Pathol. 1989 135 : 719 733.
14. Kamijo Y, Hora K, Kono K et al. PPARalpha protects proximal tubular cells from acute fatty acid toxicity. J. Am. Soc. Nephrol. 2007 18 : 3089 3100.
15. Lee SS, Pineau T, Drago J et al. Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 1995 15 : 3012 3022.
16. Hara A, Radin NS. Lipid extraction of tissues with a low-toxicity solvent. Anal. Biochem. 1978 90 : 420 426.
17. Aoyama T, Peters JM, Iritani N et al. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the Peroxisome proliferator-activated receptor alpha (PPARalpha). J. Biol. Chem. 1998 273 : 5678 5684.
18. Aoyama T, Yamano S, Waxman DJ et al. Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine. J. Biol. Chem. 1989 264 : 10388 10395.
19. Ogawa D, Shikata K, Honke K et al. Cerebroside sulfotransferase deficiency ameliorates L-selectin-dependent monocyte infiltration in the kidney after ureteral obstruction. J. Biol. Chem. 2004 279 : 2085 2090.
20. Shikata K, Suzuki Y, Wada J et al. L-selectin and its ligands mediate infiltration of mononuclear cells into kidney interstitium after ureteric obstruction. J. Pathol. 1999 188 : 93 9.
21. Nagai K, Tadano-Aritomi K, Niimura Y, Ishizuka I. Effect of nutritional substrate on sulfolipids metabolic turnover in isolated renal tubules from rat. Proc. Jpn Acad. Ser. B Phys. Biol. Sci. 2008 84 : 24 9.